Compounds with anti-tumor activity against cancer cells bearing HER2 exon 19 mutations

• 收藏
• 分享

专利权人:

Board of Regents; The University of Texas System

发明人:

ROBICHAUX, Jacqulyne,HEYMACH, John V.

申请号：

AU2019243738

公开号：

AU2019243738A1

申请日:

2019.03.27

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

The present disclosure provides methods of treating cancer in a patient determined to have a HER2 exon 19 mutation, such as a point mutation, by administering a third- generation tyrosine kinase inhibitor, such as poziotinib.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/